Table 3.
Prevalence of Cardiovascular Risk Factorsa by Disease Population
| Total n/N (%) | ESRDb n (%) | CKDc n (%) | TXPd n (%) | p-valuee | No Formal Transition n (%) | Formal Transition n (%) | p-valuee | |
|---|---|---|---|---|---|---|---|---|
| Family history of CVD | 40/103 (38%) | 7/16 (44%) | 19/41 (46%) | 14/46 (30%) | 0.28 | 36/77 (47%) | 4/26 (15%) | <0.01 |
| Smoking | 28/145 (18%) | 4/29 (14%) | 10/55 (18%) | 14/61 (23%) | 0.56 | 21/97 (22%) | 7/48 (15%) | 0.30 |
| Hypertension | 149/194 (77%) | 36/41 (88%) | 44/67 (66%) | 69/86 (80%) | 0.02 | 101/136 (74%) | 48/58 (83%) | 0.19 |
| Left ventricular hypertrophy by echocardiogramf | 37/103 (36%) | 13/29 (45%) | 7/33 (21%) | 17/41 (41%) | 0.1 | 24/66 (36%) | 13/37 (35%) | 0.90 |
| Total Cholesterol > 200 mg/dl | 35/121 (29%) | 10/24 (42%) | 9/32 (28%) | 16/65 (25%) | 0.29 | 23/81 (28%) | 12/40 (29%) | 0.90 |
| LDL Cholesterol > 130 mg/dl | 22/85 (26%) | 10/17 (59%) | 5/23 (22%) | 7/45 (16%) | <0.01 | 13/46 (28%) | 9/39 (23%) | 0.59 |
| Elevated fasting glucose | 50/192 (26%) | 7/41 (17%) | 20/66 (30%) | 23/85 (27%) | 0.31 | 24/133 (18%) | 26/59 (44%) | <0.01 |
| Body Mass Index > 30 | 42/189 (22%) | 5/39 (13%) | 15/67 (22%) | 22/83 (27%) | 0.24 | 27/130 (21%) | 15/59 (25%) | 0.47 |
a
among those who had assessment
b
End-Stage Renal Disease (ESRD)
c
Chronic Kidney Disease (CKD)
d
Kidney Transplant (TXP)
e
Based on Taylor-linearized estimation
f
among those with hypertension